Lip Makeup Products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2020 – 2026

Latest Market Analysis Research Report on “Global Lip Makeup Products Market” has been added to Wise Guy Reports database.

PUNE , MAHARASHTRA, INDIA, March 4, 2020 /EINPresswire.com/ — Global Lip Makeup Products Industry

New Industry Study On “2020-2026 Lip Makeup Products Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

Report overview

A recently published report provides a brief overview of the Global Lip Makeup Products Market with an intuitive explanation about the product/service. This overview presents a short summary of the product/ service market and also provides historical data and future prospects of the Global Lip Makeup Products Market. The report also gives a deep analysis of the production and management technology that has been employed by the different end-user industries. The latest industry trends, competitive analysis among the key players, and detailed demographic analysis for the forecast period of 2020 to 2026 have also been mentioned in the global report. 

Try Sample of Global Lip Makeup Products Market @  https://www.wiseguyreports.com/sample-request/5026192-global-lip-makeup-products-market-research-report-2020

The major players in global Lip Makeup Products market include:
L'Oreal Group, PG, Estee Lauder, Relvon, LVMH, Shiseido, Chanel, ROHTO, Beiersdorf, DHC, Johnsonand Johnson, Avon, Jahwa

Key players

The key players in the market are adopting strategies including mergers and acquisitions, partnerships, and regional expansion to stand out among their competitors in the Global Lip Makeup Products Market. New product/service launches along with an increased focus on the R&D are some ways that are leading the key players to improve upon their market share. The Global Lip Makeup Products Market report also elaborates on how the competitive landscape of the market is changing with the new trends that are penetrating the manufacturing process. Key players are also supporting their distribution networks and channels to expand the demographic scope of their products/services. The global report also exposes how prominent vendors are contributing to market growth.

Market dynamics

The statistical data for the product/service has been provided backed by research. Moreover, the research findings have been presented in a detailed manner in the report that helps to aid the growth of the Global Lip Makeup Products Market. Additionally, the factors that hamper the growth of the market is also mentioned in the report. Some principal factors such as increasing technological innovations, various government initiatives, and programmers and the competitive landscape existing in the Global Lip Makeup Products Market for the forecast period has also been presented in the report. 

Report covers:

Comprehensive research methodology of Global Lip Makeup Products Market.
This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Lip Makeup Products Market.
Insights about market determinants which are stimulating the Global Lip Makeup Products Market.
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

For any query @  https://www.wiseguyreports.com/enquiry/5026192-global-lip-makeup-products-market-research-report-2020

Some points from table of content:

1 Lip Makeup Products Market Overview
2 Global Lip Makeup Products Market Competition by Manufacturers
3 Lip Makeup Products Retrospective Market Scenario by Region
4 Global Lip Makeup Products Historic Market Analysis by Type
5 Global Lip Makeup Products Historic Market Analysis by Application
6 Company Profiles and Key Figures in Lip Makeup Products Business
6.1 L'Oreal Group
6.1.1 Corporation Information
6.1.2 L'Oreal Group Description, Business Overview and Total Revenue
6.1.3 L'Oreal Group Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.1.4 L'Oreal Group Products Offered
6.1.5 L'Oreal Group Recent Development
6.2 PG
6.2.1 PG Lip Makeup Products Production Sites and Area Served
6.2.2 PG Description, Business Overview and Total Revenue
6.2.3 PG Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.2.4 PG Products Offered
6.2.5 PG Recent Development
6.3 Estee Lauder
6.3.1 Estee Lauder Lip Makeup Products Production Sites and Area Served
6.3.2 Estee Lauder Description, Business Overview and Total Revenue
6.3.3 Estee Lauder Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Estee Lauder Products Offered
6.3.5 Estee Lauder Recent Development
6.4 Relvon
6.4.1 Relvon Lip Makeup Products Production Sites and Area Served
6.4.2 Relvon Description, Business Overview and Total Revenue
6.4.3 Relvon Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Relvon Products Offered
6.4.5 Relvon Recent Development
6.5 LVMH
6.5.1 LVMH Lip Makeup Products Production Sites and Area Served
6.5.2 LVMH Description, Business Overview and Total Revenue
6.5.3 LVMH Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.5.4 LVMH Products Offered
6.5.5 LVMH Recent Development
6.6 Shiseido
6.6.1 Shiseido Lip Makeup Products Production Sites and Area Served
6.6.2 Shiseido Description, Business Overview and Total Revenue
6.6.3 Shiseido Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Shiseido Products Offered
6.6.5 Shiseido Recent Development
6.7 Chanel
6.6.1 Chanel Lip Makeup Products Production Sites and Area Served
6.6.2 Chanel Description, Business Overview and Total Revenue
6.6.3 Chanel Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Chanel Products Offered
6.7.5 Chanel Recent Development
6.8 ROHTO
6.8.1 ROHTO Lip Makeup Products Production Sites and Area Served
6.8.2 ROHTO Description, Business Overview and Total Revenue
6.8.3 ROHTO Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.8.4 ROHTO Products Offered
6.8.5 ROHTO Recent Development
6.9 Beiersdorf
6.9.1 Beiersdorf Lip Makeup Products Production Sites and Area Served
6.9.2 Beiersdorf Description, Business Overview and Total Revenue
6.9.3 Beiersdorf Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Beiersdorf Products Offered
6.9.5 Beiersdorf Recent Development
6.10 DHC
6.10.1 DHC Lip Makeup Products Production Sites and Area Served
6.10.2 DHC Description, Business Overview and Total Revenue
6.10.3 DHC Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.10.4 DHC Products Offered
6.10.5 DHC Recent Development
6.11 Johnsonand Johnson
6.11.1 Johnsonand Johnson Lip Makeup Products Production Sites and Area Served
6.11.2 Johnsonand Johnson Lip Makeup Products Description, Business Overview and Total Revenue
6.11.3 Johnsonand Johnson Lip Makeup Products Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Johnsonand Johnson Products Offered
6.11.5 Johnsonand Johnson Recent Development
6.12 Avon
6.12.1 Avon Lip Makeup Products Production Sites and Area Served

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
08411985042
email us here


Source: EIN Presswire

Protective Face Mask Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2020 – 2026

Latest Market Analysis Research Report on “Global Protective Face Mask Market” has been added to Wise Guy Reports database.

PUNE , MAHARASHTRA, INDIA, March 4, 2020 /EINPresswire.com/ — Global Protective Face Mask Industry

New Industry Study On “2020-2026 Protective Face Mask Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

Overview

This report provides a comprehensive analysis of the Global Protective Face Mask Market and prevalent trends with insights into the detailed definition of the product/service. The overview information includes the analysis of market profile, production, and management technology being employed for the same. The potential growth of the market has been disclosed in the report for the period of 2020 to 2026. Several factors influencing the market progress have been measured and calculated for identifying and analyzing the direction of growth of the Global Protective Face Mask Market. The study of the report also includes various key players that play a major role in deciding the impact of the product/service on the global market. 

Try Sample of Global Protective Face Mask Market @  https://www.wiseguyreports.com/sample-request/5026184-global-protective-face-mask-market-research-report-2020

The major players in global Protective Face Mask market include:
3M, Honeywell, KOWA, Kimberly-clark, Uvex, McKesson, Totobobo, CM, Hakugen, Te Yin, Shanghai Dasheng, BDS, Sinotextiles, Winner Medical, Irema, Respro, DACH

Key players

The key players in the market are adopting strategies including mergers and acquisitions, partnerships, and regional expansion to stand out among their competitors in the Global Protective Face Mask Market. New product/service launches along with an increased focus on the R&D are some ways that are leading the key players to improve upon their market share. The Global Protective Face Mask Market report also elaborates on how the competitive landscape of the market is changing with the new trends that are penetrating the manufacturing process. Key players are also supporting their distribution networks and channels to expand the demographic scope of their products/services. The global report also exposes how prominent vendors are contributing to market growth.

Research methodology

Porter’s Five Force Model has been effectively adopted that has helped in studying and observing the assessment period of 2020-2026. The market research team has also inculcated the SWOT analysis method for enabling faster decision making of the reader about the Global Protective Face Mask Market. 

 Report covers:

Comprehensive research methodology of Global Protective Face Mask Market.
This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Protective Face Mask Market.
Insights about market determinants which are stimulating the Global Protective Face Mask Market.
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

For any query @  https://www.wiseguyreports.com/enquiry/5026184-global-protective-face-mask-market-research-report-2020

Some points from table of content:

1 Protective Face Mask Market Overview
2 Global Protective Face Mask Market Competition by Manufacturers
3 Protective Face Mask Retrospective Market Scenario by Region
4 Global Protective Face Mask Historic Market Analysis by Type
5 Global Protective Face Mask Historic Market Analysis by Application
6 Company Profiles and Key Figures in Protective Face Mask Business
6.1 3M
6.1.1 Corporation Information
6.1.2 3M Description, Business Overview and Total Revenue
6.1.3 3M Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.1.4 3M Products Offered
6.1.5 3M Recent Development
6.2 Honeywell
6.2.1 Honeywell Protective Face Mask Production Sites and Area Served
6.2.2 Honeywell Description, Business Overview and Total Revenue
6.2.3 Honeywell Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Honeywell Products Offered
6.2.5 Honeywell Recent Development
6.3 KOWA
6.3.1 KOWA Protective Face Mask Production Sites and Area Served
6.3.2 KOWA Description, Business Overview and Total Revenue
6.3.3 KOWA Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.3.4 KOWA Products Offered
6.3.5 KOWA Recent Development
6.4 Kimberly-clark
6.4.1 Kimberly-clark Protective Face Mask Production Sites and Area Served
6.4.2 Kimberly-clark Description, Business Overview and Total Revenue
6.4.3 Kimberly-clark Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Kimberly-clark Products Offered
6.4.5 Kimberly-clark Recent Development
6.5 Uvex
6.5.1 Uvex Protective Face Mask Production Sites and Area Served
6.5.2 Uvex Description, Business Overview and Total Revenue
6.5.3 Uvex Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Uvex Products Offered
6.5.5 Uvex Recent Development
6.6 McKesson
6.6.1 McKesson Protective Face Mask Production Sites and Area Served
6.6.2 McKesson Description, Business Overview and Total Revenue
6.6.3 McKesson Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.6.4 McKesson Products Offered
6.6.5 McKesson Recent Development
6.7 Totobobo
6.6.1 Totobobo Protective Face Mask Production Sites and Area Served
6.6.2 Totobobo Description, Business Overview and Total Revenue
6.6.3 Totobobo Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Totobobo Products Offered
6.7.5 Totobobo Recent Development
6.8 CM
6.8.1 CM Protective Face Mask Production Sites and Area Served
6.8.2 CM Description, Business Overview and Total Revenue
6.8.3 CM Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.8.4 CM Products Offered
6.8.5 CM Recent Development
6.9 Hakugen
6.9.1 Hakugen Protective Face Mask Production Sites and Area Served
6.9.2 Hakugen Description, Business Overview and Total Revenue
6.9.3 Hakugen Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hakugen Products Offered
6.9.5 Hakugen Recent Development
6.10 Te Yin
6.10.1 Te Yin Protective Face Mask Production Sites and Area Served
6.10.2 Te Yin Description, Business Overview and Total Revenue
6.10.3 Te Yin Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Te Yin Products Offered
6.10.5 Te Yin Recent Development
6.11 Shanghai Dasheng
6.11.1 Shanghai Dasheng Protective Face Mask Production Sites and Area Served
6.11.2 Shanghai Dasheng Protective Face Mask Description, Business Overview and Total Revenue
6.11.3 Shanghai Dasheng Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Shanghai Dasheng Products Offered
6.11.5 Shanghai Dasheng Recent Development
6.12 BDS
6.12.1 BDS Protective Face Mask Production Sites and Area Served
6.12.2 BDS Protective Face Mask Description, Business Overview and Total Revenue
6.12.3 BDS Protective Face Mask Sales, Revenue and Gross Margin (2015-2020)
6.12.4 BDS Products Offered
6.12.5 BDS Recent Development
6.13 Sinotextiles
6.13.1 Sinotextiles Protective Face Mask Production Sites and Area Served

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
08411985042
email us here


Source: EIN Presswire

Phone Sanitizer Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2020 – 2026

Latest Market Analysis Research Report on “Global Phone Sanitizer Market” has been added to Wise Guy Reports database.

PUNE , MAHARASHTRA, INDIA, March 4, 2020 /EINPresswire.com/ — Global Phone Sanitizer Industry

New Industry Study On “2020-2026 Phone Sanitizer Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

Report overview

A recently published report provides a brief overview of the Global Phone Sanitizer Market with an intuitive explanation about the product/service. This overview presents a short summary of the product/ service market and also provides historical data and future prospects of the Global Phone Sanitizer Market. The report also gives a deep analysis of the production and management technology that has been employed by the different end-user industries. The latest industry trends, competitive analysis among the key players, and detailed demographic analysis for the forecast period of 2020 to 2026 have also been mentioned in the global report. 

Try Sample of Global Phone Sanitizer Market @  https://www.wiseguyreports.com/sample-request/4806216-global-phone-sanitizer-market-research-report-2020

The major players in global Phone Sanitizer market include:
PhoneSoap, Verilux, EasyCare, HP, LEDMEI, MobioClean, CleanSlate UV

Prominent Players

The major players of the Global Phone Sanitizer Market are giving in their collective efforts to build a better market reputation. They are the pillars of the worldwide market that helps the industry attain high market revenue. The key players are spread across the various regions of the world to cover a vast market space for better revenue generation.

Segmental analysis

Based on the product type, applications, and other aspects, the Global Phone Sanitizer Market has been segmented along with a regional segmentation. This segmentation has been carried out to get a precise and accurate insight into the Global Phone Sanitizer Market. The regional segmentation has also been done with regions of Latin America, the Middle East, Europe, Asia-Pacific, North America, and Africa.

Report covers:

Comprehensive research methodology of Global Phone Sanitizer Market.
This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Phone Sanitizer Market.
Insights about market determinants which are stimulating the Global Phone Sanitizer Market.
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

For any query @  https://www.wiseguyreports.com/enquiry/4806216-global-phone-sanitizer-market-research-report-2020

Some points from table of content:

1 Phone Sanitizer Market Overview
2 Global Phone Sanitizer Market Competition by Manufacturers
3 Phone Sanitizer Retrospective Market Scenario by Region
4 Global Phone Sanitizer Historic Market Analysis by Type
5 Global Phone Sanitizer Historic Market Analysis by Application
6 Company Profiles and Key Figures in Phone Sanitizer Business
6.1 PhoneSoap
6.1.1 Corporation Information
6.1.2 PhoneSoap Description, Business Overview and Total Revenue
6.1.3 PhoneSoap Phone Sanitizer Sales, Revenue and Gross Margin (2015-2020)
6.1.4 PhoneSoap Products Offered
6.1.5 PhoneSoap Recent Development
6.2 Verilux
6.2.1 Verilux Phone Sanitizer Production Sites and Area Served
6.2.2 Verilux Description, Business Overview and Total Revenue
6.2.3 Verilux Phone Sanitizer Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Verilux Products Offered
6.2.5 Verilux Recent Development
6.3 EasyCare
6.3.1 EasyCare Phone Sanitizer Production Sites and Area Served
6.3.2 EasyCare Description, Business Overview and Total Revenue
6.3.3 EasyCare Phone Sanitizer Sales, Revenue and Gross Margin (2015-2020)
6.3.4 EasyCare Products Offered
6.3.5 EasyCare Recent Development
6.4 HP
6.4.1 HP Phone Sanitizer Production Sites and Area Served
6.4.2 HP Description, Business Overview and Total Revenue
6.4.3 HP Phone Sanitizer Sales, Revenue and Gross Margin (2015-2020)
6.4.4 HP Products Offered
6.4.5 HP Recent Development
6.5 LEDMEI
6.5.1 LEDMEI Phone Sanitizer Production Sites and Area Served
6.5.2 LEDMEI Description, Business Overview and Total Revenue
6.5.3 LEDMEI Phone Sanitizer Sales, Revenue and Gross Margin (2015-2020)
6.5.4 LEDMEI Products Offered
6.5.5 LEDMEI Recent Development
6.6 MobioClean
6.6.1 MobioClean Phone Sanitizer Production Sites and Area Served
6.6.2 MobioClean Description, Business Overview and Total Revenue
6.6.3 MobioClean Phone Sanitizer Sales, Revenue and Gross Margin (2015-2020)
6.6.4 MobioClean Products Offered
6.6.5 MobioClean Recent Development
6.7 CleanSlate UV
6.6.1 CleanSlate UV Phone Sanitizer Production Sites and Area Served
6.6.2 CleanSlate UV Description, Business Overview and Total Revenue
6.6.3 CleanSlate UV Phone Sanitizer Sales, Revenue and Gross Margin (2015-2020)
6.4.4 CleanSlate UV Products Offered
6.7.5 CleanSlate UV Recent Development

7 Phone Sanitizer Manufacturing Cost Analysis
8 Marketing Channel, Distributors and Customers
9 Market Dynamics
10 Global Market Forecast
11 Research Finding and Conclusion
12 Methodology and Data Source

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
08411985042
email us here


Source: EIN Presswire

Brain Injury Awareness Day: New York Lawyers Call For More States To Adopt Bicycle Helmet Laws

Bicycle Helmet Law in the USA (Map)

Bicycle Helmet Law in the USA (Map)

Michael V. Kaplen

Michael V. Kaplen

Shana De Caro

Shana De Caro

We urge national and state lawmakers to prioritize public safety over popularity, and step up to the plate to protect our cyclists.”

— Michael V. Kaplen

PLEASANTVILLE, NEW YORK, USA, March 4, 2020 /EINPresswire.com/ — On National Brain Injury Awareness day, New York brain injury lawyers De Caro & Kaplen, LLP, urge State lawmakers across the US to adopt tougher bicycle helmet laws.

The US currently has no federal laws governing helmet use, with provisions left to the discretion of each State.

Michael V. Kaplen, a partner in the firm, who served as Chair of the Motor Vehicle and Highway Liability Section of the American Association for Justice, highlighted several statistics to support the firm’s calls, “In 2016, a large study of over 64,000 Australian cyclists concluded that wearing a helmet reduces the risk of fatal head injury by 65%. This is supported by data from the Insurance Institute for Highway Safety, which shows that at least 4 out of every 5 cyclists killed on American roads between 1994 and 2018 were not wearing a helmet.”

But according to Kaplen, the majority of American cyclists choose not to wear a helmet, “A 2012 study found that just 29% of adults, and 42% of children in the USA always wear a helmet while cycling.”

21 States currently have state-wide laws requiring helmets to be worn while cycling. However, in each of these states provisions do not apply to adults, with cut off points ranging from 12 to 18 years old.

Of the remaining States, 16 have individual localities with local ordinances in place, while 13 States currently have no state-wide, or local helmet laws.

In Washington DC, cyclists under the age of 16 are prohibited from riding without a helmet.

Kaplen rejects arguments that enforcing helmet use would impinge on individual liberty and freedom of choice, “When nationwide seatbelt laws were introduced in the 80s, there was grumbling, there was pushback, but now we don’t think twice about it. Putting on a helmet when we’re cycling should be exactly the same. The data clearly shows that fatalities from head injury would be reduced if more Americans chose to protect their heads with helmets. We urge national and state lawmakers to prioritize public safety over popularity, and step up to the plate to protect our cyclists.”

To highlight the issue, De Caro & Kaplen have launched a new webpage, which includes a map of bicycle helmet laws at State and local levels, and statistics on the effectiveness of helmet use.

On Wednesday, De Caro & Kaplen, LLP partners Shana De Caro and Michael Kaplen will join representatives of the Brain Injury Association of America and its state affiliates to mark Brain Injury Awareness Day. In addition to calling for legislators to review helmet laws, they will press for limits on tackling in youth football, and urge continuation of the Federal TBI State Grant Program, Centers for Disease Control and Prevention TBI Programs, and brain injury research conducted by the TBI Model Systems. Firm partner, Shana De Caro serves as vice-chair of the Brain Injury Association of America.

The brain injury law firm has also announced later in March they will launch the third video in their series highlighting the experiences of individuals with traumatic brain injury, and the impact on their families. The new video, provisionally titled “The Little Bird Who Forgot How To Fly”, will focus on telling the story of parents of children with traumatic brain injury.

Brain Injury Awareness Day is part of Brain Injury Awareness Month — an annual public awareness campaign led by the Brain Injury Association of America to educate the public about the incidence of brain injury, and the needs of those with brain injuries and their families, and advocate on their behalf with our legislators.

De Caro & Kaplen’s page on bicycle helmet laws is available on their website at https://brainlaw.com/bicycle-helmet-law/.

Michael V. Kaplen
De Caro & Kaplen, LLP
(914) 747 4410
email us here


Source: EIN Presswire

Calls for Baker Act Reform Continue to Leave Parents Out of the Solution

During 2017-2018 there were a staggering 36,078 involuntary psychiatric examinations initiated on children across the state.

During 2017-2018 there were a staggering 36,078 involuntary psychiatric examinations initiated on children across the state.

The headquarters for CCHR Florida are located in downtown Clearwater.

The headquarters for CCHR Florida are located in downtown Clearwater.

The Florida chapter of CCHR is a non-profit mental health watchdog dedicated to the protection of children.

The Florida chapter of CCHR is a non-profit mental health watchdog dedicated to the protection of children.

 Florida law allows for a child of any age to be taken into custody and sent for an involuntary psychiatric examination.

Florida law allows for a child of any age to be taken into custody and sent for an involuntary psychiatric examination.

It was reported during the Baker Act Task Force that an estimated 30% of the children being Baker Acted in Pinellas County alone did not meet the criteria.

It was reported during the Baker Act Task Force that an estimated 30% of the children being Baker Acted in Pinellas County alone did not meet the criteria.

Recent media on the Baker Acting of children spurred calls for reformation yet the most obvious solution of bringing parents into the process is being ignored.

Improper Baker Acting of children in Florida has been going on for decades and the fundamental right of a parent to help their child is being disregarded in Florida.”

— Diane Stein, President CCHR Florida

CLEARWATER, FLORIDA, UNITED STATES, March 3, 2020 /EINPresswire.com/ — The mental health law in Florida, commonly called the Baker Act, allows for anyone, no matter their age, to be taken into custody for an involuntary psychiatric examination. This includes children and during 2017-2018 there were a staggering 36,078 involuntary psychiatric examinations initiated on children across the state according to the Baker Act Reporting Center. Even more disturbing is that over 4,000 of these Baker Acts involved children 10 and younger. [1]

According to the Florida chapter of the Citizens Commission on Human Rights (CCHR), the police body cam recording of one calm, well-mannered 6-year-old child being sent to a psychiatric facility which shocked viewers across the United States and made international news in February is an all too common occurrence. [2]

“Unfortunately, what happened to this little girl is not an isolated incident,” stated Diane Stein, President of CCHR Florida. “Improper Baker Acting of children in Florida has been going on for decades.”

While the number of children Baker Acted has been steadily climbing for the past 17 years, the trauma suffered and the resultant harm to children and their families has only recently become the subject of extensive media coverage on local, national and international news. [1,2,3,4]

This increased news coverage may be one reason why, for the last 3 years, bills have come before Florida legislators to protect children from unjust, involuntary examination in a psychiatric receiving facility, a Baker Act. These bills, meant to give parents the right to protect their children from the trauma of a Baker Act incident, among other protections, have never made it through to become law.

Multiple bills presented this session once again attempted to address this situation by requiring parental notification prior to the initiation of a Baker Act and in doing so give parents and caregivers the opportunity to help their child. As the law currently stands, a parent does not have to be notified before their child is taken from school, often in a police vehicle, and at times in handcuffs, for an involuntary psychiatric examination. However, the law does allow for a person in crisis to be helped by “willing family members or friends”. Unfortunately, this common sense approach to reducing the number of unnecessary child Baker Acts was once again ignored and left out of legislative solutions to the problem with none of the bills this session requiring parental notification making it out of committee. [5]

“The fundamental right of a parent to help their child is being disregarded in Florida,” said Diane Stein. “Several bills proposed over the last three years would have gone far to protect children in the state from improper mental health intervention and restore parental rights but these bills languished in committees.”

CCHR believes that while the current law, if executed correctly, would allow for a parent to be brought into the process before a Baker Act, it needs to be amended to specifically state that a parent, legal guardian or caregiver should be notified as a first course of action.

A barrier to this change appears to be the mistaken belief that the existing law already covers parental notification, but this notification is only after a Baker Act is initiated and the child must be taken into custody and transported to a psychiatric ward. In other words, under current law, notification is too late for the parents to take any effective action to help their child.

Misconceptions surrounding the Baker Act are common place and spurred CCHR to launch an educational campaign to inform families of their rights under the mental health law. Through the use of free workshops, seminars and mailings CCHR has educated over 220,000 families across Florida and vows to continue pressing legislators to amend the law to require parental notification prior to the initiation of a Baker Act on a child. For more information on the Baker Act, your rights as a parent or to report abuse please call 800-782-2878.

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969. For more information please visit www.cchrflorida.org.

Sources:
[1] The Baker Act, The Florida Mental Health Act Fiscal Year 2016/2017 Annual Report, Released June 2018 – Prepared for the Florida Department of Children and Families by the Baker Act Reporting Center
https://www.usf.edu/cbcs/baker-act/documents/ba_usf_annual_report_2017_2018.pdf
[2] 6-year-old Florida girl "traumatized" after being involuntarily sent to mental health facility https://www.cbsnews.com/news/florida-baker-act-6-year-old-girl-sent-to-mental-health-facility-by-school/
[3] Woman upset after officer Baker Acted 9-year-old son http://www.wftv.com/news/local/woman-upset-after-officer-baker-acted-9-year-old-s/107160305
[4] Florida’s flawed Baker Act rips thousands of kids from school https://www.tampabay.com/news/education/2019/12/10/floridas-flawed-baker-act-rips-thousands-of-kids-from-school/
[5] Florida Involuntary Examination Criteria http://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0300-0399/0394/0394.html

Diane Stein
Citizens Commission on Human Rights of Florida
+1 727-422-8820
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Children in Crisis, Florida’s Baker Acted kids | I-Team Investigates


Source: EIN Presswire

Community Oncology Files Amicus Brief with Supreme Court Supporting State Regulation of PBMs

COA and Practices Strongly Support Right of States to Step Up and Do What is Right for Vulnerable Patients

Arkansas and other states must be allowed to do what is right for vulnerable patients by regulating PBMs.”

— Ted Okon, executive director of COA

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, March 3, 2020 /EINPresswire.com/ — The Community Oncology Alliance and several leading community oncology practices filed an Amicus Curiae brief with the Supreme Court this week supporting the rights of states to regulate Pharmacy Benefit Managers (PBMs).

In the brief, community oncology strongly supports the need for states to be able to stop PBM abuses, especially those that are hurting patients with cancer. In recent years, PBMs have increasingly inserted themselves between oncologists and their patients, adversely impacting the delivery of cancer care.

“The constitution is clear that elected officials at the state level have a duty and authority to enact policies to protect the health and well-being of their citizens. Unfortunately, inaction by Congress and misguided policy by this administration have allowed PBMs to increasingly dominate our cancer care system. We applaud all the states stepping up to stop PBM abuses,” said Ted Okon, executive director of COA. “PBMs have been nothing but a plague for cancer patients, who face delays and denials in accessing their life-saving medications. Arkansas and other states must be allowed to do what is right for vulnerable patients by regulating PBMs.”

Read COA’s Amicus Curiae brief in Rutledge v. the Pharmaceutical Care Management Association.

The case before the Supreme Court is Rutledge v. the Pharmaceutical Care Management Association, and it is set to be heard in late April. The Arkansas Attorney General is Leslie Rutledge and the PCMA is the professional lobbying group that represents PBMs. The PCMA sued the state of Arkansas after it found that PBMs were violating the state’s Deceptive Trade Practices Act, reimbursing pharmacies below the pharmacies’ cost to acquire the medication.

The details of this case and news stories about PBMs typically focus on the adverse financial impact of PBMs on pharmacy providers, which the community oncology brief does as well. However, the brief also informs the court how “low-ball” reimbursement tactics are being used by PBMs to steer business to their own mail-order pharmacies, which is adversely impacting patient care. COA collects reports of real-life patient horror stories at the hands of PBMs and the suffering they cause by delaying delivery of critical cancer drugs, denying coverage, and arguing with physicians over proper treatment, among other abuses. These include PBM horror stories like those published in the Fresno Bee, Columbus Dispatch and STAT News.

Although Congress is considering legislation to regulate PBMs’ bad behavior, the Administration has actually given PBMs more power, instead of less. These include dangerous practices like “fail-first” step therapy and formulary restrictions, which oncologists know don’t work and actually harm patients. Community oncology has been warning that without significant state or federal action, PBM abuses will undermine the incredible, lifesaving progress the United States has made in treating cancer and reducing mortality due to the disease.

COA and community oncology practices are actively working to address the high cost of cancer drugs and services. As the frontline providers of care for the majority of Americans battling cancer, independent community oncologists are uniquely positioned to give insight into the real-world impact of policymaking on patients, providers, and the overall health care system. Community oncology practices that joined COA in this brief include Florida Cancer Specialists & Research Institute; New York Cancer and Blood Specialists; Regional Cancer Care Associates; Tennessee Oncology; Texas Oncology; and the Quality Cancer Care Alliance.

Read COA’s Amicus Curiae brief in Rutledge v. the Pharmaceutical Care Management Association at https://communityoncology.org/wp-content/uploads/2020/03/18-540tsacCommunityOncologyAllianceInc.pdf

Nicolas Ferreyros
Community Oncology Alliance
+1 2027298147
email us here


Source: EIN Presswire

Adam Ferrari Releases Video Showcasing Nonprofit Next Steps of Chicago

Ferrari Energy founder Adam Ferrari has released a YouTube video showcasing the work of nonprofit organization Next Steps of Chicago.

DENVER, COLORADO , USA, March 3, 2020 /EINPresswire.com/ — Adam Ferrari, the founder of Ferrari Energy, released a video on YouTube that showcases the incredible work done at the nonprofit Next Steps of Chicago. The video focuses specifically on a typical day of rehabilitation training for Adam’s father, Dan Ferrari, who became quadriplegic at the age of 67 in 2016.

Following along with Adam and Dan, viewers can see various spaces within the Next Steps of Chicago facility, including equipment, exercise areas, and the waiting area. The video features Dan’s rehabilitation exercises, including using the Nustep T5 machine to work both arms and legs, assisted arm lifts, electric stimulation therapy, and sit forward movements. Next Steps of Chicago provides physical therapists, physical therapy assistants, and personal trainers working together to provide activity-based, functional, and specific locomotor training for individuals diagnosed with neurological disorders.

Throughout the video, Next Steps of Chicago’s team of trainers and therapists are seen assisting Mr. Ferrari through the exercises, giving viewers a glimpse of the work that is done in the facility every day. At Next Steps of Chicago, clients and therapists work together to improve health and achieve functional goals. Every day the staff at Next Steps of Chicago help individuals like Dan Ferrari to improve their trunk stability, posture, balance, strength, transferability and even walking and standing. They also help individuals with neurological conditions participate in sports and increase bone density, cardiovascular and pulmonary function, and glucose tolerance in addition to decreasing spasticity and the risk of skin lesions.

Next Steps of Chicago was the first nonprofit, free-standing physical therapy and exercise facility devoted to rehabilitation and overall wellness of people living with devastating and challenging disorders and injuries, including SCI, Traumatic Brain Injury, Stroke, Cerebral Palsy, Parkinson’s, Multiple Sclerosis, and many other neurological conditions. Next Steps of Chicago helps patients regain a higher quality of life by aiding them toward an independent, healthy, functional lifestyle. The organization also integrates and conducts scientific research in hopes of finding a cure for paralysis.

Giving back to the community is important to Adam Ferrari, and Next Steps of Chicago is an organization near to his heart because they have been caring for his father since his diagnosis. In addition to partnering with Next Steps of Chicago, Ferrari Energy has made meaningful donations to many nonprofit organizations in Chicago and Denver, including Coats for Colorado, the Denver Rescue Mission, Freedom Service Dogs, and St. Jude Children’s Hospital.

About Adam Ferrari:
Adam Ferrari is the founder of the Denver-based mineral acquisitions company Ferrari Energy. An accomplished petroleum engineer with a degree in chemical engineering, Adam was inspired to learn more about property rights and the inner workings of petroleum exploration and extraction through various roles he held in the oil and gas industry. He then obtained knowledge of the financial industry through his time at an investment banking firm.

Adam Ferrari combined his knowledge of energy and finance to build Ferrari Energy from the ground up, shifting his perspective to work directly with people on a personal level. The company has provided over 2,000 landowners divestment and lease opportunities on their respective lands. Under Adam’s leadership, his company has also made meaningful contributions to many non-profit organizations in Chicago and Denver including Coats for Colorado, the Denver Rescue Mission, Freedom Service Dogs, Next Steps of Chicago, and St. Jude Children’s Hospital.

Adam Ferrari
Ferrari Energy
+1 720-230-6618
email us here

Adam Ferrari Supports Next Steps of Chicago for Spinal Trauma and Neurological Disorders


Source: EIN Presswire

Stem Cell Therapy for Coronavirus Infection

Vitro Biopharma reports on a potential therapy of Coronavirus (COVID-19) infections by stem cell transplant.

Vitro Diagnostics Inc. (OTCMKTS:VODG)

We are pleased to be positioned to offer stem cell therapy for Coronavirus infection.”

— Dr. James Musick

GOLDEN, COLORADO, UNITED STATES, March 3, 2020 /EINPresswire.com/ — Stem Cell Therapy for Coronavirus Infection

GOLDEN, CO,March 3 2020 /Vitro Diagnostics, Inc. (OTCPK:VODG), dba Vitro Biopharma reports on a potential therapy of Coronavirus (COVID-19) infections by stem cell transplant. While this therapy is not a method to eradicate or cure Coronavirus, there is evidence to support the concept that infected patients may be more likely to combat and survive infection. First, stem cells resist viral attack by the expression of certain genes known as interferon gamma stimulated genes (ISGs). These are expressed in stem cells prior to their differentiation. (Wu, X, et al, Cell 172: 423, 2018). Hence, stem cells would be expected to survive even if transplanted into a patient with an active Coronavirus infection. Also, it is known that stem cells rejuvenate and regenerate cells in the body through various processes involving reduction of inflammation, secretion of substances that protect cells, transfer of mitochondria, reduction of cell death, anti-oxidative effects and improvement of immune system function. These effects are likely to increase survival in patients infected with Coronavirus. Also, there is direct evidence of stem cell protection against viral infection. Influenza virus A/H5N1 causes acute lung injury that was reduced by human mesenchymal stromal cells (MSCs) in mice and the treatment increased survival (Chan, et al, PNAS 113:3621, 2016).

Vitro Biopharma has operated a highly regulated, FDA-compliant commercial biologics manufacturing facility for several years and is cGMP compliant, ISO9001 Certified, ISO13485 Certified, CLIA Certified and FDA registered. All clinical manufacturing occurs in a certified sterile clean room with extensive and advanced testing to assure the absence of contamination. Furthermore, in numerous patients treated to date by IV infusion of our AlloRx Stem Cells™ there have been no significant adverse events while we have gained evidence of efficacy. We presently supply our AlloRx™ Stem Cells to DVC Stem in the Cayman Islands for treatment of inflammatory conditions. We plan to begin recruitment of patients for a trial of stem cell therapy of musculoskeletal conditions in the Bahamas during spring 2020.

Dr. Jim Musick, CEO said, "We are pleased to be positioned to offer stem cell therapy for Coronavirus infection. While there are several factors related to the possible extent of this global infection, stem cell therapy represents a therapeutic option to fight the virus and increase survival while effective vaccines are being developed. Our existing off-shore partners offer stem cell transplant services and we are in contact with CDC officials regarding potential US-based stem cell transplants into infected individuals."

About Vitro Biopharma

Vitro Biopharma, for over 10 years, has supplied major biopharmaceutical firms, elite university laboratories and clinical trials worldwide with Mesenchymal Stem Cells, the MSC-Grow™ Brand of cell culture media, various stem cell derivatives and stem cell-derived differentiated cells. We also manufacture primary fibroblast cells and an expanding line of cancer-associated fibroblasts (CAFs) from various tumors including lung, breast, melanoma, pancreatic, glioblastoma and colorectal tissues. Our CAFs are purchased by major pharmaceutical and biopharmaceutical firms to advance immunotherapy of cancer.

Out of our years of research, we developed our patent-pending and proprietary line of umbilical cord-derived stem cells AlloRx™ Stem Cells now being used in offshore regenerative medicine clinical trials. Our stem cells are used in regenerative medicine clinical trials with our partner in the Cayman Islands www.DVCStem.com. We have a recently approved clinical trial using our AlloRx™ Stem Cells to treat musculoskeletal conditions at The Medical Pavilion of the Bahamas www.tmp-bahamas.com in Nassau. We are supporting clinical studies of stem cell therapies using our AlloRx™ Stem Cells for osteoarthritis, neurodegenerative diseases including Parkinson's disease, Multiple Sclerosis and Alzheimer's disease while pursuing select US markets for stem cell therapies.

We support our regenerative therapies with NutraVivo™/STEMulize™, a nutraceutical Stem Cell Activator that has been shown to induce proliferation, migration and epigenetic modification of human adult stem cells. NutraVivo™ improves overall cellular wellness and significantly increases expression of anti-aging genes.

Forward-Looking Statements

Statements herein regarding financial performance have not yet been reported to the SEC nor reviewed by the Company's auditors. Certain statements contained herein and subsequent statements made by and on behalf of the Company, whether oral or written may contain "forward-looking statements". Such forward-looking statements are identified by words such as "intends," "anticipates," "believes," "expects" and "hopes" and include, without limitation, statements regarding the Company's plan of business operations, product research and development activities, potential contractual arrangements, receipt of working capital, anticipated revenues and related expenditures. Factors that could cause actual results to differ materially include, among others, acceptability of the Company's products in the market place, general economic conditions, receipt of additional working capital, the overall state of the biotechnology industry and other factors set forth in the Company's filings with the Securities and Exchange Commission. Most of these factors are outside the control of the Company. Investors are cautioned not to put undue reliance on forward-looking statements. Except as otherwise required by applicable securities statutes or regulations, the Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT:

Dr. James Musick
Chief Executive Officer
Vitro Biopharma
(303) 999-2130 Ext. 1
E-mail: jim@vitrobiopharma.com

SOURCE: Vitro Diagnostics, Inc.

John Evans
Vitro BioPharma
+1 303-601-7855
email us here


Source: EIN Presswire

Coronavirus and Shincheonji: Stopping the Witch Hunt

Shincheonji congregation currently facing surge of religious persecution due to COVID-19 outbreak in Daegu, South Korea

NEW YORK, NEW YORK, UNITED STATES, March 3, 2020 /EINPresswire.com/ — In recent days the COVID-19 outbreak has not only caused issues related to public health and global markets, but religious freedom. This letter was addressed to H.E. Michelle Bachelet, UN High Commissioner of Human Rights, and H.E. Ambassador Sam Brownback, US Ambassador-at-Large for International Religious Freedom by Center for Studies on New Religions on March 2, 2020.

“Dear President Bachelet and Ambassador Brownback:
Center for Studies on New Religions (CESNUR) is an international NGO specialized in the defense of religious liberty. We are deeply concerned with a growing number of instances of intolerance and discrimination against Shincheonji, Church of Jesus, a new South Korean religious movement. This concern has grown after a number of its members were diagnosed with COVID-19.

Shincheonji was founded by a Korean preacher named Man Hee Lee. There is persecution from mainstream religious groups because they say Lee regards himself as God, or as the second coming of Jesus. Rather, he refers to himself as the “promised pastor.”

Arch-conservative Protestantism is the largest segment of Protestant Christianity in South Korea. It has promoted campaigns against Shincheonji and has labeled it a “cult.” Shincheonji has been particularly targeted because its growth has largely led to a decline in Protestant churches.

Several thousand Shincheonji members have been detained by or on behalf of their family members in order to compel them to renounce their faith through “deprogramming.” After Ms. Gu Ji-in died during a programming attempt, more than 120,000 Koreans took to the streets and demanded a halt to the practice. The protests were mentioned in the 2019 U.S. State Department Report on Religious Freedom, under violations of religious freedom of the previous year.

Opponents have effectively demonized Shincheonji through South Korean media outlets. As a result, many members of Shincheonji in South Korea chose not to disclose their membership in Shincheonji in their workplaces, schools, and other social circles in fear of negative repercussions. To avoid prejudice, certain activities of Shincheonji were advertised under alternative names and therefore accusations of dissimulation have been made. More recently Shincheonji participated in “open evangelism,” disclosing its name when organizing both religious and non-religious events. Regardless, members of Shincheonji have faced discrimination. Some have lost employment when their affiliation with the church becomes known to their supervisors.

It is important to note, Coronavirus had spread in South Korea before Patient 31. Patient 31 is a female member of Shincheonji from Daegu, South Korea. She was not aware of her condition and was diagnosed as positive to the virus only when hospitalized after a car accident. Meanwhile, she had attended several Shincheonji events, which led to spreading the virus to fellow congregants, who now account for a significant percentage of those infected in South Korea.
After Patient 31’s condition became known, Shincheonji halted its religious gatherings all over the country, and supplied to the authorities the list of national congregants (which exceeds 200,000 members) on the condition their personal information would be protected. It also tested many of its members at its own expense. Some authorities have complained that lists were not complete, this has resulted in misunderstandings and animosity. However, Shincheonji supplied what was requested, i.e. a list of its members, not including persons, referred to as “students,” who have expressed an initial interest in Shincheonji and visit its (Bible) centers, but are not members. When the authorities requested the lists of students, they were also submitted.

Korean politicians scapegoat Shincheonji for the virus epidemic, perhaps to dodge accusations against their own mishandling of the crisis. South Korea will have general elections on April 15, and blaming Shincheonji is a convenient way both to avoid a wider debate on how the authorities handled the epidemic and to court the bloc vote of Protestants, for whom combating Shincheonji is high priority on the agenda.

Protestants are also spreading fake news about Shincheonji and the virus. They include claims that infected Shincheonji members were ordered not to report to hospitals. The opposite is true. In addition, reports that the church believes that its members cannot really be infected as they are protected by God is also not true. The idea that devotees regard infection as something good, as suffering can be offered to the Lord is untrue. Finally, the heinous idea that infected Shincheonji members go around and try to infect others is untrue. These misconceptions have led to unnecessary violence.

In Daegu, government workers distributing masks were beaten after a chain-text message falsely informed the population that those workers were Shincheonji members trying to infect others. In Ulsan, on February 26, a female Shincheonji member died after falling from a window on the 7th floor of her apartment building. There was a history of domestic violence related to her involvement in Shincheonji. The police are investigating foul play. The lists of Shincheonji members supplied to the authorities have been partially leaked, and Shincheonji devotees have been publicly insulted and beaten, or lost employment.

Rather than apologizing for the shortfalls of the government, they call for the dissolution of Shincheonji and the criminal prosecution of its leaders, with the pre-electoral support of politicians.The hysteria is growing every day, further violence is imminent and we believe that the only way of stopping it is to bring international awareness of the dire situation. We call on the United Nations, the United States, and supporters of religious liberty to denounce the discriminatory treatment of Shincheonji. The South Korean government, societal leaders, and citizens must continue to put effort into containing and managing COVID-19. Energies must not be used shifting responsibility, but working cooperatively to mitigate this global crisis.”

Representative from these organizations signed this letter: The Center for Studies on New Religions, International Observatory of Religious Liberty of Refugees, European Federation for Freedom of Belief, Coordination of Associations and Persons for Freedom of Conscience, European Inter-religious Forum for Religious Freedom, Forum for Religious Freedom Europe, Center for Studies on Freedom of Belief, Religion and Conscience, Human Rights Without Frontiers and Soteria International.

Cheonji News Representative
Cheonji News
+1 646 628 7365
email us here


Source: EIN Presswire

REDBUD LABS Extends MXR Chip Line

MXR DryPak component allows reagents to be resuspended on-cartridged

Reagent resuspension with MXR DryPak

Redbud's expands its “mixer” microfluidic chip family with MXR™DryPak chip which incorporates assay reagents dried inside for use in high-performance POC tests.

Assembling a cartridge with dry reagents on-board . . . result in expensive, hard-to-manufacture products. MXR™DryPak replaces all of this complexity with a single part . . .”

— Dr. Jay Fisher, Vice President of R & D

RESEARCH TRIANGLE PARK, NORTH CAROLINA, UNITED STATES, March 3, 2020 /EINPresswire.com/ — Redbud Labs announced today an expansion to its MXRTM (“mixer”) microfluidic chip family with the introduction of the MXR™DryPak chip. The new MXR™DryPak microfluidic chips combine Redbud Post® technology for microfluidic mixing with assay reagents dried inside. Like all of Redbud’s chip products, MXR™DryPak is cartridge-ready™ and optimal for use in high-performance point-of care (POC) tests. MXR™DryPak enables developers of sample-to-answer systems to design simpler, more cost-effective cartridges with greater multiplexing, better assay performance, and shorter time-to-result.

MXR™DryPak leverages Redbud’s highly scalable manufacturing methods. MXR chips are assembled by laminating sheets of Redbud Posts into microfluidic chambers before dicing out individual chips. Chips are then used as components in consumable cartridges. MXR™DryPak builds on this production method by loading customers’ reagents onto a layer in the chip assembly. The process uses conventional dispensing methods and is fully isolated from the microfabrication methods used to produce Redbud Posts. The result is a fully scalable process that integrates with existing reagent production workflows and requirements. Redbud’s R&D team is fully equipped to support system developers as they optimize their reagent formulations within MXR™DryPak chips, and Redbud’s Operations team can rapidly scale with customer demand on both rapid-turn, short-run production and ongoing volume manufacturing.

“Our customers have been using MXR chips to boost reaction yields in amplification, lysis, and other critical workflows,” said Dr. Jay Fisher, Vice President of R & D. “Assembling a cartridge with dry reagents on-board has always required a combination of methods—injection molding, filling, drying, pick-and-place—that result in expensive, hard-to-manufacture products. MXR™DryPak replaces all of this complexity with a single part that manufacturers install with a simple pick-and-place operation.”

Redbud’s MXR chips are recognized for their rapid mixing capability in microfluidic volumes where reliance upon diffusion kinetics limits the performance of sample-to-answer assays. MXR chip models are assembled microfluidic components, well-suited for use with microarrays, reagent reconstitution and microfluidic cartridges. This new MXR™DryPak model rounds out Redbud’s MXR chip line. It follows the recent launch of STR™BeadPak, the only universal, ready-to-use sample prep solution for microfluidic cartridges.

ABOUT REDBUD

Redbud Labs, headquartered in Research Triangle Park, North Carolina, manufacturers breakthrough components for life science industry, intended to solve the industry’s ubiquitous microscale fluidic challenges. Redbud technologies have broad application across a variety of segments including basic research, drug discovery and development, biomanufacturing, diagnostics, sequencing and applied markets. Industry partners seek Redbud’s proprietary microchip technology, component design expertise and deep scientific know-how to advance their own next generation products. Redbud Posts® are an array of flexible, magnetic micropillars printed on a silicone film that can be affixed to a substrate. Redbud Posts® rotate in response to a magnetic field, inducing microfluidic agitation for rapid and efficient target capture. Rebudlabs.com

For further information contact:

Kathryn Lawrence
Redbud Labs Inc.
+1 919-537-9753
email us here


Source: EIN Presswire